WHO ICTRP trial
The effect of a disease-specific supplement on the postprandial plasma glucose…
NL-OMON23712 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON23712 |
|---|---|
| Public title | The effect of a disease-specific supplement on the postprandial plasma glucose response in type 2 diabetic patients at baseline and after 6 and 12 weeks of supplementation. |
| Scientific title | The effect of a disease-specific supplement on the postprandial plasma glucose response in type 2 diabetic patients at baseline and after 6 and 12 weeks of supplementation. |
| Primary sponsor | Numico Research B.V. P.O. Box 7005 6700 CA Wageningen Bosrandweg 20 6704 PH Wageningen The Netherlands Tel: +31 (0)317 467 800 Fax: +31 (0)317 466 500 |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Conditions | Type 2 diabetic patients in need of nutritional support. |
| Interventions | Duration intervention: 12 weeks Intervention group: disease specific sipfeed. Control group: isocaloric standard sipfeed. |
| Registration date | Apr 12, 2006 |
| Target size | 34 |
| Secondary IDs | NL597;NTR653; : 100015;ISRCTN86065299 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: